125 related articles for article (PubMed ID: 3520347)
1. [T-lymphocyte purification of donor bone marrow in allogeneic bone marrow transplantation for leukemia: a step ahead or a breakthrough?].
von dem Borne AE
Ned Tijdschr Geneeskd; 1986 May; 130(19):852-4. PubMed ID: 3520347
[No Abstract] [Full Text] [Related]
2. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
5. Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells.
Verdonck LF; Petersen EJ; Lokhorst HM; Nieuwenhuis HK; Dekker AW; Tilanus MG; de Weger RA
Bone Marrow Transplant; 1998 Dec; 22(11):1057-63. PubMed ID: 9877267
[TBL] [Abstract][Full Text] [Related]
6. [Donor leukocyte transfusion in a patient with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation: analysis of natural killer cell activity and T-cell receptor repertoire in bone marrow T cells that exhibited graft-versus-leukemia activity].
Suehiro Y; Muta K; Umemura T; Motomura S; Nishimura J; Nawata H; Kimura N
Rinsho Ketsueki; 1999 Jan; 40(1):40-5. PubMed ID: 10067095
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in patients with leukemia].
Löwenberg B; Sizoo W; Wagemaker G; Sintnicolaas K; Hendriks WD; Hagenbeek A
Ned Tijdschr Geneeskd; 1986 May; 130(19):872-6. PubMed ID: 3520349
[No Abstract] [Full Text] [Related]
8. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
9. [Indication of unrelated donor bone marrow transplantation for refractory leukemia].
Oh H
Rinsho Ketsueki; 1996 Aug; 37(8):671-5. PubMed ID: 8827876
[No Abstract] [Full Text] [Related]
10. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
11. Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation.
Bargetzi MJ; Schönenberger A; Tichelli A; Fried R; Cathomas G; Signer E; Speck B; Gratwohl A
Bone Marrow Transplant; 1997 Oct; 20(7):607-9. PubMed ID: 9337064
[TBL] [Abstract][Full Text] [Related]
12. Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors.
Goldman FD; Rumelhart SL; DeAlacron P; Holida MD; Lee NF; Miller J; Trigg M; Giller R
Bone Marrow Transplant; 2000 May; 25(9):943-8. PubMed ID: 10800061
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
[TBL] [Abstract][Full Text] [Related]
14. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation.
Kline RM; Stiehm ER; Cowan MJ
Bone Marrow Transplant; 1996 Apr; 17(4):543-8. PubMed ID: 8722352
[TBL] [Abstract][Full Text] [Related]
16. Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrow.
Trigg ME; Sondel PM; Billing R; Finlay JL; Peterson A; Hong R; Frierdich S; Shahidi N
J Biol Response Mod; 1985 Dec; 4(6):602-12. PubMed ID: 3910764
[TBL] [Abstract][Full Text] [Related]
17. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation.
Au WY; Lam CC; Lie AK; Pang A; Kwong YL
Am J Clin Pathol; 2003 Oct; 120(4):626-30. PubMed ID: 14560574
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
[TBL] [Abstract][Full Text] [Related]
19. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
[TBL] [Abstract][Full Text] [Related]
20. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
